thomas mckee

thomas mckee

Université de Genève

H-index: 32

Europe-Switzerland

About thomas mckee

thomas mckee, With an exceptional h-index of 32 and a recent h-index of 21 (since 2020), a distinguished researcher at Université de Genève, specializes in the field of Pathology, cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency–Associated Genomic Instability in Ovarian Cancer

PO009/# 424 Innovative academic homologous recombination deficiency tests available in advanced ovarian cancer: the European ENGOT initiative

Effectiveness of Fractionated Rituximab in Preventing Tumor Lysis Syndrome in Aggressive B-Cell Lymphoma: Insights from Real-Life Clinical Practice

CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers

3-O sulfation of syndecan-1 mediated by the sulfotransferase HS3ST3a1 enhances myeloma aggressiveness

Normalized LST is an efficient biomarker for homologous recombination deficiency and Olaparib response in ovarian carcinoma

Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma

1275 Mapping the heterogeneous colorectal tumor microenvironment with multiplexed imaging and machine learning

thomas mckee Information

University

Position

Professor of Pathology

Citations(all)

4372

Citations(since 2020)

1703

Cited By

3218

hIndex(all)

32

hIndex(since 2020)

21

i10Index(all)

70

i10Index(since 2020)

43

Email

University Profile Page

Google Scholar

thomas mckee Skills & Research Interests

Pathology

cancer

Top articles of thomas mckee

High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency–Associated Genomic Instability in Ovarian Cancer

JCO Precision Oncology

2024/3

PO009/# 424 Innovative academic homologous recombination deficiency tests available in advanced ovarian cancer: the European ENGOT initiative

2023/11/1

Effectiveness of Fractionated Rituximab in Preventing Tumor Lysis Syndrome in Aggressive B-Cell Lymphoma: Insights from Real-Life Clinical Practice

Authorea Preprints

2023/10/9

Thomas Mckee
Thomas Mckee

H-Index: 18

3-O sulfation of syndecan-1 mediated by the sulfotransferase HS3ST3a1 enhances myeloma aggressiveness

Matrix Biology

2023/6/1

Normalized LST is an efficient biomarker for homologous recombination deficiency and Olaparib response in ovarian carcinoma

JCO Precision Oncology

2023/6

Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma

Journal of Experimental & Clinical Cancer Research

2023/4/3

1275 Mapping the heterogeneous colorectal tumor microenvironment with multiplexed imaging and machine learning

2022/11/1

2022-RA-567-ESGO The Geneva HRD test: clinical validation on 469 samples from the PAOLA-1 trial

2022/10/1

FOLFOXIRI resistance induction and characterization in human colorectal cancer Cells

Cancers

2022/9/30

Cohort profile: population-based cohorts of patients with colorectal cancer and of their relatives in Geneva, Switzerland

BMJ open

2022/8/1

Thomas Mckee
Thomas Mckee

H-Index: 18

Thomas Zilli
Thomas Zilli

H-Index: 20

Study protocol of a phase II study to evaluate safety and efficacy of neo-adjuvant pembrolizumab and radiotherapy in localized rectal cancer

BMC cancer

2022/7/15

Thomas Mckee
Thomas Mckee

H-Index: 18

Thomas Zilli
Thomas Zilli

H-Index: 20

727 HRD scoring with a SNP assay

International Journal of Gynecological Cancer

2021/10/1

201 Homologous recombination deficiency testing in advanced ovarian cancer: description of the ENGOT HRD European initiative

2021/10/1

Targeting OLFML3 in colorectal cancer suppresses tumor growth and angiogenesis, and increases the efficacy of anti-PD1 based immunotherapy

Cancers

2021/9/15

Ovarian cancer with high-level focal ERBB2 amplification responds to trastuzumab and pertuzumab

Gynecologic Oncology Reports

2021/8/1

Use of Diagnostic Algorithms for NTRK Fusion-Positive Tumors in Pathology Institutes in Switzerland

healthbook TIMES Oncology Hematology

2021/3/9

Unmasking viral sequences in human blood samples during graft-versus-host disease

2021/2/25

Immunologic clearance of a BK virus-associated metastatic renal allograft carcinoma

Transplantation

2021/2/1

Automated detection of arm-level alterations for individual cancer patients in the clinical setting

The Journal of Molecular Diagnostics

2021/12/1

See List of Professors in thomas mckee University(Université de Genève)